A carregar...
TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
Modern vaccines have largely shifted from using whole, killed or attenuated pathogens to being based on subunit components. Since this diminishes immunogenicity, vaccine adjuvants that enhance the immune response to purified antigens are critically needed. Further advantages of adjuvants include dos...
Na minha lista:
| Publicado no: | Pharmaceutics |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7911620/ https://ncbi.nlm.nih.gov/pubmed/33499143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13020142 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|